The correct classification: Pure GLP-1 agonists: exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, efpeglenatide, orforglipron Dual GIP/GLP-1 agonists: tirzepatide Triple agonists (GIP/GLP-1/glucagon): retatrutide Retatrutide, approved in early 2026, adds glucagon receptor agonism to the dual GIP/GLP-1 mechanism
Its componentsincluding L-Carnitine, Choline, Methionine, Inositol, and B vitaminshave been extensively studied for their individual physiological roles and are commonly investigated together to better understand how these interconnected metabolic pathways influence cellular energy production and normal liver physiology
Why Are GLP-1 Medications So Expensive in the U.S
Meanwhile, the EGFP module in our sorting tag allows convenient evaluation of the positive cells through fluorescent microscopy and flow cytometry